Related Experiment Video
Updated: May 10, 2025
Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
Ginger: A Nutraceutical Supplement for Protection Against Various Cardiovascular Diseases in Clinical Trials
Taherah Mohammadabadi1,2, Aimen E Ben Ayad3,4,2, Akhil Maheshwari5,6,2
1Faculty of Animal Science and Food Technology, Agricultural Sciences and Natural Resources University, Mollasani, IRN.
Abstract:
Cardiovascular diseases (CVDs) are increasing in prevalence, causing significant health issues and remaining one of the leading causes of death worldwide. Medical herbs continue to be used as an alternative treatment approach for several diseases, including various CVDs. Since ancient times, certain herbs have been safely used to alleviate the risk of developing CVD and control or improve the symptoms of medical conditions, such as in cases of congestive heart failure, angina, atherosclerosis, and systolic hypertension. Ginger is one of the medicinal herbs that neutral agents use to prevent and treat various CVDs. Ginger has antioxidant, anti-inflammatory, and immunomodulatory components and may improve cardiovascular risk factors. The natural components of ginger effectively inhibit inflammation, oxidative stress, and insulin resistance; may reduce fasting blood glucose, triglyceride, and low-density lipoprotein (LDL) levels; and prevent CVDs. Ginger can be an alternative that has lower side effects. Ginger's bioactive components may improve human blood lipid profile and decrease blood sugar levels. Further research is necessary to confirm ginger phytochemicals' efficacy and mechanism for various CVDs. The present review aims to summarize the effects of ginger's bioactive compounds on cardiovascular diseases.
More Related Videos
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
08:53Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model
Published on: December 9, 2018
Related Concept Videos
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...